M. Wurster

Anticoagulation management: a new approach.

M. Wurster, T. Doran, 2006, Disease management : DM.

Patient self-testing for management of anticoagulation therapy: challenges

M. Wurster, 2008, Journal of Thrombosis and Thrombolysis.

National experience with an electronic medical record for anticoagulation therapy

J. Woyach, M. Wurster, 2008, Journal of Thrombosis and Thrombolysis.

Malignancy-induced lactic acidosis.

G. Doolittle, M. Wurster, C. Rosenfeld, 1988, Southern medical journal.

Social and ethical controversies in thrombophilia testing and update on genetic risk factors for venous thromboembolism.

B. Kerlin, E. Varga, M. Wurster, 2008, Seminars in thrombosis and hemostasis.

A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis

P. Malfertheiner, H. Bonkovsky, P. Brissot, 2010, Hepatology.

A Phase I/II, Open-Label, Dose-Escalation Trial of Once-Daily Oral Chelator Deferasirox to Treat Iron Overload in HFE-Related Hereditary Hemochromatosis: Final Results of the Core Study.

H. Bonkovsky, P. Brissot, W. Stremmel, 2009 .

187 A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE-RELATED HEREDITARY HEMOCHROMATOSIS: FINAL RESULTS

P. Malfertheiner, H. Bonkovsky, P. Brissot, 2009 .

[Proximal tibial fractures sustained during alpine skiing - incidence and risk factors].

P. Augat, O. Gonschorek, V. Bühren, 2013, Sportverletzung Sportschaden : Organ der Gesellschaft fur Orthopadisch-Traumatologische Sportmedizin.

Personalized healthcare in clotting disorders.

D. Sedmak, C. Marsh, Haifeng M. Wu, 2010, Personalized medicine.

STABLE results: warfarin home monitoring achieves excellent INR control.

G. Desantis, J. Ansell, K. Kupfer, 2014, The American journal of managed care.